ArticleBMC cardiovascular disorders2026
Association Between Life's Crucial 9 and the prevalence of coronary heart disease in U.S. adults: the potential role of the systemic inflammatory response index.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThis studyaimed to examine the association between Life's Crucial 9 (LC9) score and the prevalence of coronary heart disease (CHD) among U.S. adults, as well as explore the potential statistical contribution of Systemic Inflammatory Response Index (SIRI) in this association.
methodsData were obtained from 23,508 participants in the National Health and Nutrition Examination Survey (NHANES) from 2005 to 2018. LC9 score quartiles were used to summarize continuous and categorical variables, which were then reported as weighted means ± standard deviations or weighted frequencies and proportions, respectively. Differences among groups were examined using weighted t-tests and weighted chi-square tests. The relationship between LC9 scores, Ln-SIRI values, and the prevalence of CHD was investigated using weighted logistic regression models following the natural logarithmic transformation of skewed SIRI results. Furthermore, restricted cubic spline regression was utilized to investigate plausible nonlinear connections, subgroup and likelihood ratio tests investigated interaction effects, and weighted quantile sum (WQS) regression was incorporated to determine the relative contributions of LC9 components to CHD. An exploratory non-causal mediation analysis using 1,000 bootstrap samples was conducted to assess SIRI as a potential statistical explanatory variable in the association between LC9 and the prevalence of CHD.
resultsIn Model 3, a 10-point increase in the LC9 score correlated with a 24% decrease in the odds of CHD prevalence; participants in the Q4 group had 59% lower odds of CHD compared with those in the Q1 group (P < 0.001 trend). Each Ln-SIRI unit was associated with 56% higher odds of CHD, with Q4 showing 2.02-fold higher odds than Q1 (P < 0.001 trend). Restricted cubic spline regression revealed linear relationships between LC9, Ln-SIRI, and the prevalence of CHD. In particular, LC9 was negatively associated with CHD, whereas Ln-SIRI was positively associated with CHD. Age significantly moderated the association between LC9 and CHD (P for interaction < 0.05), with stronger inverse associations in younger adults. WQS regression identified glucose (weight = 0.34) and tobacco (weight = 0.33) as key CHD-associated factors. Exploratory non-causal mediation analysis revealed that about 6.5% of the LC9-CHD relationship was statistically accounted for by SIRI (P < 0.001), with the majority of factors associated with the link remaining unexplained. This indicates that other factors may be the primary contributors to the LC9-CHD relationship.
conclusionThis study showed that higher LC9 scores were significantly associated with lower odds of prevalent self-reported CHD, while higher SIRI was associated with higher odds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.